Okla. judge orders Johnson & Johnson to pay $572 million for opioid crisis

Cleveland County District Judge Thad Balkman made a landmark ruling, which found Johnson & Johnson liable for fueling an opioid epidemic in Oklahoma. (Photo credit: Reuters as reported by The Washington Post on 8/26/19.)

Cleveland County District Judge Thad Balkman made a landmark ruling, which found Johnson & Johnson liable for fueling an opioid epidemic in Oklahoma. (Photo credit: Reuters as reported by The Washington Post on 8/26/19.)

Johnson & Johnson must pay the state of Oklahoma $572 million in the first opioid-related state case to go to trial.

Cleveland County (Okla.) District Judge Thad Balkman found the pharmaceutical company responsible for the opioid crisis in Oklahoma, one of more than 40 states waging lawsuits, The Washington Post reports.

Judge Balkman issued his ruling Monday, Aug. 26, which The Post dubbed a “landmark decision” and “the first to hold a drugmaker culpable for the fallout of years of liberal opioid dispensing that began in the late 199os.”

An estimated 400,000 people have died of overdoses from painkillers, heroin and illegal fentanyl since 1999. according to the report.

Oklahoma attorneys sought $17.5 billion over 30 years for treatment, emergency care, law enforcement, social services, and other addiction-related needs, but Judge Balkman ordered Johnson & Johnson to pay $572 million “to remedy the drug crisis in the first year, based on the state’s plan,” The Post reports. The company has vowed to appeal.

California official sues maker of Humira, alleging kickbacks

Photo credit: www.abbvie.com

Photo credit: www.abbvie.com

The state of California is suing AbbVie Inc. over its flagship drug, Humira, alleging the pharmaceutical company gave kickbacks to healthcare providers.

Reuters reported in mid-September on the complaint, brought by Insurance Commissioner Dave Jones.

“The regulator alleged that AbbVie engaged in a far-reaching scheme including cash, meals, drinks, gifts, trips, and patient referrals, as well as free and valuable professional goods and services to physicians to induce and reward Humira prescriptions,” Reuters reported.

“The case, filed in Alameda County Superior Court, alleged that private insurers have paid out $1.2 billion in Humira-related pharmacy claims.”

AbbVie defended its actions, saying it complies with state and federal law and that “it provides a number of support services for patients, once they are prescribed Humira, that both educate and assist patients with their therapy, including nursing support.”